Pricing Log in Create free account
Tuesday 3 November 2026 Export OSCR’s income statement to Excel — free account

Oscar Health, Inc.

OSCR Healthcare Healthcare Plans

Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.

Revenue
+70.4%
EPS
+234.8%
Free cash flow
+316.3%
Total debt
+43.9%

Quarter to June 2026, against a year earlier

31.08 0.71 +2.34%
Market cap
$9.6B
P/E
18.2×
Fwd P/E
15.8×
Dividend yield
—
F-score
3/9
Altman Z
1.07
Beneish M
−2.18
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Filings

Oscar Health, Inc. (OSCR) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 16, 2026 7.01 Regulation FD disclosure
10-Q Jun 30, 2026 P1I2: 4 added · 36 modified
P2I1A: no changes
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 4, 2026 5.07 Submission of matters to a vote of security holders
8-K Jun 8, 2026 7.01 Regulation FD disclosure
8-K May 29, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Mar 31, 2026
8-K May 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 21, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 7.01 Regulation FD disclosure
10-K Dec 31, 2025 1: 6 added · 4 removed · 71 modified
1A: 28 added · 10 removed · 140 modified
7: 21 added · 21 removed · 52 modified
8-K Feb 6, 2026 1.01 Entry into a material definitive agreement; 2.02 Results of operations and financial condition; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Dec 22, 2025 5.02 Departure or appointment of directors or officers
10-Q Sep 30, 2025
8-K Nov 3, 2025 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 18, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 3.02 Unregistered sales of equity securities; 9.01 Financial statements and exhibits
8-K Sep 15, 2025 1.02 Termination of a material definitive agreement; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 15, 2025 1.01 Entry into a material definitive agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 3, 2025 7.01 Regulation FD disclosure
10-Q Jun 30, 2025
8-K Aug 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 22, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Jan 29, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 10, 2024 2.02 Results of operations and financial condition
8-K Nov 7, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.